Vaccines for SARS coronavirus 2 and the new normal in vaccinology.
作者信息
Griffiths P D
出版信息
Rev Med Virol. 2021 Mar;31(2):e2229. doi: 10.1002/rmv.2229. Epub 2021 Mar 5.
Abstract
摘要
相似文献
1
Vaccines for SARS coronavirus 2 and the new normal in vaccinology.严重急性呼吸综合征冠状病毒2疫苗与疫苗学的新常态
Rev Med Virol. 2021 Mar;31(2):e2229. doi: 10.1002/rmv.2229. Epub 2021 Mar 5.
2
Editorial: Challenges in Vaccinology.社论：疫苗学中的挑战
Front Immunol. 2020 Dec 17;11:632537. doi: 10.3389/fimmu.2020.632537. eCollection 2020.
3
The lightning-fast quest for COVID vaccines - and what it means for other diseases.对新冠疫苗的闪电式探索及其对其他疾病的意义。
Nature. 2021 Jan;589(7840):16-18. doi: 10.1038/d41586-020-03626-1.
4
Could mixing COVID vaccines boost immune response?混合接种新冠疫苗能增强免疫反应吗？
Nature. 2021 Feb;590(7846):375-376. doi: 10.1038/d41586-021-00315-5.
5
How COVID unlocked the power of RNA vaccines.新冠疫情如何开启了RNA疫苗的力量。
Nature. 2021 Jan;589(7841):189-191. doi: 10.1038/d41586-021-00019-w.
6
Vaccinology - Editorial.疫苗学——编者按
Semin Immunol. 2020 Aug;50:101439. doi: 10.1016/j.smim.2020.101439. Epub 2020 Dec 7.
7
Covid-19 vaccines: delivering protective immunity.新冠疫苗：提供保护性免疫
BMJ. 2020 Dec 17;371:m4838. doi: 10.1136/bmj.m4838.
8
Lessons From Bacille Calmette-Guérin for SARS-CoV-2 Vaccine Candidates.从卡介苗（BCG）看新冠病毒候选疫苗。
J Infect Dis. 2021 Feb 3;223(2):189-191. doi: 10.1093/infdis/jiaa637.
9
Why Oxford's positive COVID vaccine results are puzzling scientists.为何牛津大学新冠疫苗的阳性结果令科学家们感到困惑。
Nature. 2020 Dec;588(7836):16-18. doi: 10.1038/d41586-020-03326-w.
10
Messenger RNA vaccines against SARS-CoV-2.针对 SARS-CoV-2 的信使 RNA 疫苗。
Cell. 2021 Mar 18;184(6):1401. doi: 10.1016/j.cell.2020.12.039. Epub 2021 Jan 13.
本文引用的文献
1
Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia.基于 rAd26 和 rAd5 载体的异源初免-加强型 COVID-19 疫苗的安全性和有效性：俄罗斯一项随机对照 3 期临床试验的中期分析。
Lancet. 2021 Feb 20;397(10275):671-681. doi: 10.1016/S0140-6736(21)00234-8. Epub 2021 Feb 2.
2
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.mRNA-1273 新型冠状病毒疫苗的有效性和安全性。
N Engl J Med. 2021 Feb 4;384(5):403-416. doi: 10.1056/NEJMoa2035389. Epub 2020 Dec 30.
3
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.ChAdOx1 nCoV-19 疫苗（阿斯利康）对 SARS-CoV-2 的安全性和有效性：巴西、南非和英国四项随机对照试验的中期分析。
Lancet. 2021 Jan 9;397(10269):99-111. doi: 10.1016/S0140-6736(20)32661-1. Epub 2020 Dec 8.
4
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.BNT162b2 mRNA 新冠病毒疫苗的安全性和有效性。
N Engl J Med. 2020 Dec 31;383(27):2603-2615. doi: 10.1056/NEJMoa2034577. Epub 2020 Dec 10.
5
Emergence of novel coronavirus and progress toward treatment and vaccine.新型冠状病毒的出现以及治疗和疫苗的研发进展。
Rev Med Virol. 2020 Jul;30(4):e2116. doi: 10.1002/rmv.2116. Epub 2020 Jun 4.
6
Opportunities and Challenges in the Delivery of mRNA-based Vaccines.基于信使核糖核酸的疫苗交付中的机遇与挑战。
Pharmaceutics. 2020 Jan 28;12(2):102. doi: 10.3390/pharmaceutics12020102.
7
Influenza: options to improve pandemic preparation.流感：改善大流行准备的选择。
Science. 2012 Jun 22;336(6088):1531-3. doi: 10.1126/science.1221466.
Zotero 插件